Matsui K, Sawa T, Suzuki H, Nakagawa K, Okamoto N, Tada T, Nagano T, Masuda N. Relapse of Stage I Small Cell Lung Cancer Ten or More Years after the Start of Treatment.
Jpn J Clin Oncol 2006;
36:457-61. [PMID:
16782728 DOI:
10.1093/jjco/hyl044]
[Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Most patients with small cell lung cancer (SCLC) usually show relapse within 1 or 2 years. Relapses after a 5-year disease-free survival are extremely rare. This report describes two patients with stage I SCLC in whom the disease recurred 10 or more years after the start of initial therapy. Because the recurrence of SCLC was noted in the mediastinal lymph nodes of the same side, we concluded that the patients had a late relapse of SCLC rather than a metachronous lung cancer.
Collapse